跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
BEYFORTUS nirsevimab 100mg in 1mL solution for injection prefilled syringe
Approved
STANDARD
BEYFORTUS nirsevimab 100mg in 1mL solution for injection prefilled syringe
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
21b22850f9ef4b22
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
21b22850f9ef4b22
Product Name
BEYFORTUS nirsevimab 100mg in 1mL solution for injection prefilled syringe
Artg Id
397899
Artg Name
BEYFORTUS nirsevimab 100mg in 1mL solution for injection prefilled syringe
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2023-11-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0815d87b6f23ea340fdcf98480da1ca1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/26da4019bd315201013cf8f2cdbeaa5f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
21b22850f9ef4b22
Type
Standard
Back to TGA Approvals
BEYFORTUS nirsevimab 100mg in 1mL solution for injection prefilled syringe - TGA Drug Approval Details